dr tyna moore glp-1 I was joined by Dr. and Calley Means on The Doctor Hyman Show, where we explored both sides of using GLP-1s. We challenge the notion of treating obesity, discuss its benefits, and how our GLP-1s are NOT the answer!

First, you can appeal

However, studies on targeted segments of the population have shown that the upper limit of 15mol/L is far too high in well-nourished populations without obvious vitamin deficiency

Popular and effective injectable drugs like Ozempic, Wegovy, and Mounjaro contain semaglutide, a GLP-1 receptor agonist

The great majority of individuals (90%) in which red-blood cell zinc and red-blood cell copper were both measured demonstrated an abnormality in at least one

131 These peripheral effects may secondarily influence central insulin signalling, highlighting the potential of multireceptor agonism to modulate metabolic, inflammatory, and mitochondrial dysfunction in neurodegenerative contexts